글로벌 인유두종바이러스(HPV) 관련 질환 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 인유두종바이러스(HPV) 관련 장애 시장

인간유두종바이러스(HPV) 관련 질환 시장은 2021년부터 2028년까지의 예측 기간 동안 4.62%의 잠재적 성장률을 기록할 것으로 예상됩니다. 암 관련 연구 및 발전에 소요되는 지출이 크게 증가한 것이 시장 성장의 원인입니다.

인간유두종바이러스(HPV)는 가장 흔한 성병 중 하나이며, 다양한 유형의 HPV가 흔하며 그 중 일부는 생명을 위협하는 장애와 질병을 일으킵니다. HPV 감염으로 인한 장애에는 사마귀, 자궁경부암 , 항문암 등이 있습니다. 

HPV 관련 질환 및 상태로 고통받는 환자 수의 증가는 2021년에서 2028년의 예측 기간 동안 시장 성장을 가속화할 것으로 예상됩니다. 마찬가지로 HPV 관련 질환의 유병률 증가와 치료 옵션의 침투 증가도 인간 유두종 바이러스(HPV) 관련 질환 시장 성장을 강화할 것으로 예측됩니다. 나아가 HPV 관련 질환의 유병률 증가와 이를 치료하기 위한 새로운 치료법의 강력한 존재도 시장 성장률을 견인할 것으로 예상됩니다.

또한, 개발 도상국과 저개발 경제권에서 의료 분야의 급속한 기술 발전, 소비자 인식 제고, 의료 인프라에 대한 높은 투자는 2021년에서 2028년까지의 예측 기간 동안 인간유두종바이러스(HPV) 관련 질환 시장 성장에 영향을 미칠 다양한 새로운 기회를 창출할 가능성이 높습니다.

그러나 대중 사이에서 백신과 HPV에 대한 지식이 부족하고, 치료법의 장기적인 부정적 영향에 대한 우려가 커지면서 인간유두종바이러스(HPV) 관련 질환 시장 성장이 크게 제약받을 것으로 예상됩니다. 진단 및 치료에 대한 인식 부족은 위에 언급된 예측 기간 동안 타겟 시장 성장에 어려움을 줄 수 있습니다.

This human papillomavirus (HPV) associated disorders market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the human papillomavirus (HPV) associated disorders market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Human Papillomavirus (HPV) Associated Disorders Market Scope and Market size

Human papillomavirus (HPV) associated disorders market is segmented on the basis of indication, therapy and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• Based on indication, the human papillomavirus (HPV) associated disorders market can be segmented into cervical intraepithelial neoplasia (CIN), cervical cancer, anal intraepithelial neoplasia (AIN), anal cancer, genital warts and others.
• The therapy segment of the human papillomavirus (HPV) associated disorders market can be segmented into prevention and treatment.
• On the basis of distribution channel, the human papillomavirus (HPV) associated disorders market can be segmented into hospital pharmacies, retail pharmacies and online pharmacies.

Human Papillomavirus (HPV) Associated Disorders Market Country Level Analysis

Human papillomavirus (HPV) associated disorders market is analyzed and market size information is provided by country by indication, therapy and distribution channel as referenced above.

The countries covered in the human papillomavirus (HPV) associated disorders market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the human papillomavirus (HPV) associated disorders market due to the strong commercial sales of biologics in the U.S., rise in healthcare expenditure and local presence of key manufacturers. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the rapid economic development, development in healthcare infrastructure and rise in disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Human papillomavirus (HPV) associated disorders market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Human Papillomavirus (HPV) Associated Disorders Market Share Analysis

Human papillomavirus (HPV) associated disorders market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to human papillomavirus (HPV) associated disorders market.

The major players covered in the human papillomavirus (HPV) associated disorders market report are Merck & Co., Inc., Allergan, GlaxoSmithKline plc, Cytovation AS, Biocon, Pfizer Inc., AstraZeneca, Novartis AG, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company and Advaxis among other domestic and global players. Human papillomavirus (HPV) associated disorders market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-46054